Description: The actuarial profession is changing rapidly and the skills needed to be successful are also changing. In this session, we will debate key topics and questions, such as: What is the predominant future career path for actuaries? Specialists or generalists? Does the actuarial profession have a meaningful value prop outside our core domains e.g. insurance? What skills are needed for the actuary of the future? What’s the best approach to improve actuarial storytelling to non-actuarial audiences? What’s the role of actuaries to managing and predicting emerging trends and assumptions? What is the role of actuaries in relation to development and ownership of advanced modeling? Is the future actuarial profession smaller/larger than it is today? In either case, how does it differ from today in terms of make-up, deployment, function, purpose, value add, etc.?

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: The Society of Actuaries (SOA) Research Institute’s Mortality and Longevity Strategic Research Program Steering Committee established a call for essays series to gather a variety of perspectives on the application of AI to mortality and longevity. The objective of this call for essays, the second in the series, is to create a resource that focuses on the use of AI to potentially extend human longevity and the implications for modeling future survival/mortality.

Description: Attend this webcast to learn more on how to navigate managing ESG principles in the new normal of a post-COVID world. Enhance your ESG insights in a post-pandemic landscape.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: En el seminario hablaremos sobre los nuevos flujos de tarificación, y nos enfocaremos en la inclusión del análisis geográfico en el proceso de modelado para optimizar la extracción del riesgo en modelos de Machine Learning.

Description: Learn how modernization of data, models, and technology are influencing workflows. This webcast will address how workflows are changing in response to new regulatory requirements and the impacts the changes have on modeling and end-to-end future state operating models. Industry leading actuaries will discuss: How team collaboration can increase quality and speed of reporting to internal and external stakeholders How to strengthen controls and compliance frameworks across finance and actuarial departments How to modernize actuarial input/output for strategic analysis and insights How to attract and retain top talent by improving opportunities for actuaries There will also be dedicated time to ask questions of those who have made the transition.

Description: This article helps actuaries who may have excellent business ideas to take the first step of starting a business

Description: This session will discuss essential theories and practical applications of deep learning for actuaries. Participants will gain insights on leveraging these cutting-edge techniques to enhance actuarial models and drive predictive accuracy.